Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin, Exenatide, and Glargine Insulin in Combination for Treatment of Patients With Type 2 Diabetes

NCT00667732 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT00667732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00667732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin, Exenatide, and Glargine Insulin in Combination for Treatment of Patients With Type 2 Diabetes
Lead sponsor
Oregon Health and Science University
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2007
Completion date
April 30, 2010
Enrollment
41 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes